Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for siRNAs
Most Correlated Studies
- Ovarian cancer Hey-A8 cells with triplet nucleotide repeat-based CAG/CUG or CGA/UCG siRNA
- Preadipocytes expressing LMO3 siRNA
- Ovarian cancer OVCAR-3 cells with POU5F1 siRNA, CCNF siRNA, PPP1R8 siRNA or RB1 siRNA
- Hepatocytes with RETSAT siRNA knockdown
- Prostate adenocarcinoma C4-2B cells with HOXC6 siRNA or DLX1 siRNA knockdown
Most Relevant Literature
- PhasiRNAnalyzer: an integrated analyser for plant phased siRNAs.
- Nanobody-siRNA Conjugates for Targeted Delivery of siRNA to Cancer Cells.
- Environment-Responsive Lipid/siRNA Nanoparticles for Cancer Therapy.
- Pulmonary siRNA delivery for lung disease: Review of recent progress and challenges.
- Synthesis and use of an amphiphilic dendrimer for siRNA delivery into primary immune cells.
Most Relevant Clinical Trials
- EphA2 siRNA in Treating Patients With Advanced or Recurrent Solid Tumors
- A Dose Escalation Trial of an Intravitreal Injection of Sirna-027 in Patients With Subfoveal Choroid…
- Study of TD101, a Small Interfering RNA (siRNA) Designed for Treatment of Pachyonychia Congenita
- Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Lipo…
- iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
